3-D Matrix, Ltd.
3-D Matrix, Ltd. DMTRF Peers
See (DMTRF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DMTRF | $0.69 | N/A | 76.1M | -9.86 | -$0.07 | N/A |
| SEMHF | $55.30 | -0.36% | 62B | 26.21 | $2.11 | +2.03% |
| SMMNY | $26.58 | -1.39% | 59.6B | 25.32 | $1.05 | +1.26% |
| RYLPF | $23.23 | -0.04% | 21.5B | 77.42 | $0.30 | +4.09% |
| SONVF | $315.35 | +0.00% | 18.8B | 28.64 | $11.01 | +1.87% |
| SONVY | $62.25 | -2.18% | 18.6B | 28.30 | $2.20 | +1.53% |
| SNNUF | $14.21 | -0.63% | 12.4B | 30.23 | $0.47 | +2.64% |
| CHEOY | $87.36 | -1.18% | 11.4B | 46.97 | $1.86 | +1.60% |
| CHEOF | $167.01 | -1.76% | 10.9B | 45.51 | $3.67 | +1.66% |
| WILYY | $19.25 | +4.94% | 8.2B | 19.06 | $1.01 | N/A |
Stock Comparison
DMTRF vs SEMHF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SEMHF has a market cap of 62B. Regarding current trading prices, DMTRF is priced at $0.69, while SEMHF trades at $55.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SEMHF's P/E ratio is 26.21. In terms of profitability, DMTRF's ROE is -0.24%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, DMTRF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs SMMNY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SMMNY has a market cap of 59.6B. Regarding current trading prices, DMTRF is priced at $0.69, while SMMNY trades at $26.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SMMNY's P/E ratio is 25.32. In terms of profitability, DMTRF's ROE is -0.24%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, DMTRF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs RYLPF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, RYLPF has a market cap of 21.5B. Regarding current trading prices, DMTRF is priced at $0.69, while RYLPF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas RYLPF's P/E ratio is 77.42. In terms of profitability, DMTRF's ROE is -0.24%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, DMTRF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs SONVF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SONVF has a market cap of 18.8B. Regarding current trading prices, DMTRF is priced at $0.69, while SONVF trades at $315.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SONVF's P/E ratio is 28.64. In terms of profitability, DMTRF's ROE is -0.24%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, DMTRF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs SONVY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SONVY has a market cap of 18.6B. Regarding current trading prices, DMTRF is priced at $0.69, while SONVY trades at $62.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SONVY's P/E ratio is 28.30. In terms of profitability, DMTRF's ROE is -0.24%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, DMTRF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs SNNUF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SNNUF has a market cap of 12.4B. Regarding current trading prices, DMTRF is priced at $0.69, while SNNUF trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SNNUF's P/E ratio is 30.23. In terms of profitability, DMTRF's ROE is -0.24%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CHEOY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CHEOY has a market cap of 11.4B. Regarding current trading prices, DMTRF is priced at $0.69, while CHEOY trades at $87.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CHEOY's P/E ratio is 46.97. In terms of profitability, DMTRF's ROE is -0.24%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, DMTRF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CHEOF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CHEOF has a market cap of 10.9B. Regarding current trading prices, DMTRF is priced at $0.69, while CHEOF trades at $167.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CHEOF's P/E ratio is 45.51. In terms of profitability, DMTRF's ROE is -0.24%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, DMTRF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs WILYY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, WILYY has a market cap of 8.2B. Regarding current trading prices, DMTRF is priced at $0.69, while WILYY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas WILYY's P/E ratio is 19.06. In terms of profitability, DMTRF's ROE is -0.24%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, DMTRF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs WILLF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, WILLF has a market cap of 7.9B. Regarding current trading prices, DMTRF is priced at $0.69, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas WILLF's P/E ratio is 18.93. In terms of profitability, DMTRF's ROE is -0.24%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, DMTRF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs GNGBF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, GNGBF has a market cap of 5.4B. Regarding current trading prices, DMTRF is priced at $0.69, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas GNGBF's P/E ratio is 37.04. In terms of profitability, DMTRF's ROE is -0.24%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, DMTRF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs GNGBY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, GNGBY has a market cap of 5.3B. Regarding current trading prices, DMTRF is priced at $0.69, while GNGBY trades at $19.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas GNGBY's P/E ratio is 33.63. In terms of profitability, DMTRF's ROE is -0.24%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, DMTRF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs AMBBY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, AMBBY has a market cap of 4.2B. Regarding current trading prices, DMTRF is priced at $0.69, while AMBBY trades at $15.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas AMBBY's P/E ratio is 75.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, DMTRF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs AMBFF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, AMBFF has a market cap of 4B. Regarding current trading prices, DMTRF is priced at $0.69, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, DMTRF's ROE is -0.24%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, DMTRF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs NHNKY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, NHNKY has a market cap of 3.7B. Regarding current trading prices, DMTRF is priced at $0.69, while NHNKY trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas NHNKY's P/E ratio is 18.32. In terms of profitability, DMTRF's ROE is -0.24%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, DMTRF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs NHNKF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, DMTRF is priced at $0.69, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, DMTRF's ROE is -0.24%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, DMTRF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs VTRLY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, VTRLY has a market cap of 2.2B. Regarding current trading prices, DMTRF is priced at $0.69, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, DMTRF's ROE is -0.24%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, DMTRF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs GNNDY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, DMTRF is priced at $0.69, while GNNDY trades at $43.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas GNNDY's P/E ratio is 17.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs STSEY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, DMTRF is priced at $0.69, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas STSEY's P/E ratio is 39.41. In terms of profitability, DMTRF's ROE is -0.24%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, DMTRF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs GGNDF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, GGNDF has a market cap of 1.9B. Regarding current trading prices, DMTRF is priced at $0.69, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas GGNDF's P/E ratio is 15.48. In terms of profitability, DMTRF's ROE is -0.24%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs OSSFF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, DMTRF is priced at $0.69, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, DMTRF's ROE is -0.24%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, DMTRF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs DWRKF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, DMTRF is priced at $0.69, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, DMTRF's ROE is -0.24%, compared to DWRKF's ROE of N/A. Regarding short-term risk, DMTRF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs MCRPF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, MCRPF has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $0.69, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, DMTRF's ROE is -0.24%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, DMTRF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs OSSUY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $0.69, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, DMTRF's ROE is -0.24%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, DMTRF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs MEDGF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $0.69, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, DMTRF's ROE is -0.24%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, DMTRF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs DRWKF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, DRWKF has a market cap of 1.3B. Regarding current trading prices, DMTRF is priced at $0.69, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas DRWKF's P/E ratio is 8.96. In terms of profitability, DMTRF's ROE is -0.24%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, DMTRF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs DGWPF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, DMTRF is priced at $0.69, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas DGWPF's P/E ratio is 7.58. In terms of profitability, DMTRF's ROE is -0.24%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, DMTRF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs XVIPF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, XVIPF has a market cap of 1B. Regarding current trading prices, DMTRF is priced at $0.69, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, DMTRF's ROE is -0.24%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, DMTRF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs LFTSF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, DMTRF is priced at $0.69, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, DMTRF's ROE is -0.24%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, DMTRF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs SSII Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SSII has a market cap of 975.8M. Regarding current trading prices, DMTRF is priced at $0.69, while SSII trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SSII's P/E ratio is -63.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to SSII's ROE of -1.33%. Regarding short-term risk, DMTRF is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs ELEAF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, ELEAF has a market cap of 832.7M. Regarding current trading prices, DMTRF is priced at $0.69, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas ELEAF's P/E ratio is 11.94. In terms of profitability, DMTRF's ROE is -0.24%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, DMTRF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs MDRSF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, MDRSF has a market cap of 826.6M. Regarding current trading prices, DMTRF is priced at $0.69, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, DMTRF's ROE is -0.24%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, DMTRF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CALZF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CALZF has a market cap of 586.5M. Regarding current trading prices, DMTRF is priced at $0.69, while CALZF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CALZF's P/E ratio is 84.90. In terms of profitability, DMTRF's ROE is -0.24%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, DMTRF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs AVMR Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, DMTRF is priced at $0.69, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas AVMR's P/E ratio is -18.34. In terms of profitability, DMTRF's ROE is -0.24%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, DMTRF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CLVSF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, DMTRF is priced at $0.69, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, DMTRF's ROE is -0.24%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, DMTRF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs IOBCF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, IOBCF has a market cap of 404.3M. Regarding current trading prices, DMTRF is priced at $0.69, while IOBCF trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas IOBCF's P/E ratio is 36.32. In terms of profitability, DMTRF's ROE is -0.24%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs HYBT Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, DMTRF is priced at $0.69, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas HYBT's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is -0.24%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, DMTRF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs EAPIF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, EAPIF has a market cap of 290.4M. Regarding current trading prices, DMTRF is priced at $0.69, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, DMTRF's ROE is -0.24%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, DMTRF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CSSPF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CSSPF has a market cap of 263.4M. Regarding current trading prices, DMTRF is priced at $0.69, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, DMTRF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CYBQY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CYBQY has a market cap of 255.7M. Regarding current trading prices, DMTRF is priced at $0.69, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CYBQY's P/E ratio is -61.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, DMTRF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CLLKF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CLLKF has a market cap of 253.2M. Regarding current trading prices, DMTRF is priced at $0.69, while CLLKF trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CLLKF's P/E ratio is -7.97. In terms of profitability, DMTRF's ROE is -0.24%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, DMTRF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs HTLZF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, DMTRF is priced at $0.69, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, DMTRF's ROE is -0.24%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, DMTRF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs SNWV Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SNWV has a market cap of 236.3M. Regarding current trading prices, DMTRF is priced at $0.69, while SNWV trades at $27.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SNWV's P/E ratio is -4.43. In terms of profitability, DMTRF's ROE is -0.24%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, DMTRF is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs BCCOY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, DMTRF is priced at $0.69, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, DMTRF's ROE is -0.24%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, DMTRF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs IMPZY Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, DMTRF is priced at $0.69, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, DMTRF's ROE is -0.24%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, DMTRF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CYBQF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CYBQF has a market cap of 173.5M. Regarding current trading prices, DMTRF is priced at $0.69, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, DMTRF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs AVHHL Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, AVHHL has a market cap of 166M. Regarding current trading prices, DMTRF is priced at $0.69, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, DMTRF's ROE is -0.24%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, DMTRF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs BRNHF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, BRNHF has a market cap of 161.8M. Regarding current trading prices, DMTRF is priced at $0.69, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, DMTRF's ROE is -0.24%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, DMTRF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs EKDHF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, EKDHF has a market cap of 161.7M. Regarding current trading prices, DMTRF is priced at $0.69, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, DMTRF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs JMDMF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, JMDMF has a market cap of 152M. Regarding current trading prices, DMTRF is priced at $0.69, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, DMTRF's ROE is -0.24%, compared to JMDMF's ROE of N/A. Regarding short-term risk, DMTRF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs PXMBF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, PXMBF has a market cap of 144M. Regarding current trading prices, DMTRF is priced at $0.69, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, DMTRF's ROE is -0.24%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, DMTRF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs BRSYF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, BRSYF has a market cap of 128.4M. Regarding current trading prices, DMTRF is priced at $0.69, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, DMTRF's ROE is -0.24%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, DMTRF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs AMEUF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, DMTRF is priced at $0.69, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, DMTRF's ROE is -0.24%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, DMTRF is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs VMTHF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, DMTRF is priced at $0.69, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, DMTRF's ROE is -0.24%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, DMTRF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs FDMDF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, FDMDF has a market cap of 102.7M. Regarding current trading prices, DMTRF is priced at $0.69, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, DMTRF's ROE is -0.24%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, DMTRF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs RSHUF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, DMTRF is priced at $0.69, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, DMTRF's ROE is -0.24%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, DMTRF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs CKMTF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, DMTRF is priced at $0.69, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, DMTRF's ROE is -0.24%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, DMTRF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs SOMNF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SOMNF has a market cap of 84.3M. Regarding current trading prices, DMTRF is priced at $0.69, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, DMTRF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs SNZZF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, SNZZF has a market cap of 71.9M. Regarding current trading prices, DMTRF is priced at $0.69, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas SNZZF's P/E ratio is -4.91. In terms of profitability, DMTRF's ROE is -0.24%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, DMTRF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs RDGL Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, RDGL has a market cap of 58.5M. Regarding current trading prices, DMTRF is priced at $0.69, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas RDGL's P/E ratio is -12.91. In terms of profitability, DMTRF's ROE is -0.24%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, DMTRF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs BLOZF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, BLOZF has a market cap of 47.6M. Regarding current trading prices, DMTRF is priced at $0.69, while BLOZF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas BLOZF's P/E ratio is -20.65. In terms of profitability, DMTRF's ROE is -0.24%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, DMTRF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs IPDQF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, IPDQF has a market cap of 43M. Regarding current trading prices, DMTRF is priced at $0.69, while IPDQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas IPDQF's P/E ratio is -2.12. In terms of profitability, DMTRF's ROE is -0.24%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, DMTRF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs NVYTF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, NVYTF has a market cap of 38M. Regarding current trading prices, DMTRF is priced at $0.69, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas NVYTF's P/E ratio is -0.73. In terms of profitability, DMTRF's ROE is -0.24%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, DMTRF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs TLTFF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, TLTFF has a market cap of 32.2M. Regarding current trading prices, DMTRF is priced at $0.69, while TLTFF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas TLTFF's P/E ratio is -13.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, DMTRF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs ELXMF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, DMTRF is priced at $0.69, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, DMTRF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs KBBTF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, DMTRF is priced at $0.69, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, DMTRF's ROE is -0.24%, compared to KBBTF's ROE of N/A. Regarding short-term risk, DMTRF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs PYNKF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, PYNKF has a market cap of 23.4M. Regarding current trading prices, DMTRF is priced at $0.69, while PYNKF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas PYNKF's P/E ratio is -1.19. In terms of profitability, DMTRF's ROE is -0.24%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, DMTRF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs POSC Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, POSC has a market cap of 23.1M. Regarding current trading prices, DMTRF is priced at $0.69, while POSC trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas POSC's P/E ratio is 0.35. In terms of profitability, DMTRF's ROE is -0.24%, compared to POSC's ROE of +9.25%. Regarding short-term risk, DMTRF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs EMITF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, EMITF has a market cap of 22.2M. Regarding current trading prices, DMTRF is priced at $0.69, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas EMITF's P/E ratio is -14.29. In terms of profitability, DMTRF's ROE is -0.24%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, DMTRF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs DIZTF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, DIZTF has a market cap of 16.9M. Regarding current trading prices, DMTRF is priced at $0.69, while DIZTF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas DIZTF's P/E ratio is -10.50. In terms of profitability, DMTRF's ROE is -0.24%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, DMTRF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs ASAPF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, ASAPF has a market cap of 16.4M. Regarding current trading prices, DMTRF is priced at $0.69, while ASAPF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas ASAPF's P/E ratio is -21.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, DMTRF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs MDXHF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, MDXHF has a market cap of 15.5M. Regarding current trading prices, DMTRF is priced at $0.69, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, DMTRF's ROE is -0.24%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, DMTRF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs TMDIF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, DMTRF is priced at $0.69, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, DMTRF's ROE is -0.24%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, DMTRF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs VPTDF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, VPTDF has a market cap of 13.4M. Regarding current trading prices, DMTRF is priced at $0.69, while VPTDF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas VPTDF's P/E ratio is -4.11. In terms of profitability, DMTRF's ROE is -0.24%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, DMTRF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs PLLWF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, DMTRF is priced at $0.69, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, DMTRF's ROE is -0.24%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, DMTRF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs IMEXF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, IMEXF has a market cap of 11.8M. Regarding current trading prices, DMTRF is priced at $0.69, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas IMEXF's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is -0.24%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, DMTRF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs RMSL Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, RMSL has a market cap of 11.5M. Regarding current trading prices, DMTRF is priced at $0.69, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas RMSL's P/E ratio is 0.75. In terms of profitability, DMTRF's ROE is -0.24%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, DMTRF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs ATBPF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, DMTRF is priced at $0.69, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, DMTRF's ROE is -0.24%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, DMTRF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs LXXGF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, DMTRF is priced at $0.69, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, DMTRF's ROE is -0.24%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, DMTRF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs GTHP Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, GTHP has a market cap of 11M. Regarding current trading prices, DMTRF is priced at $0.69, while GTHP trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas GTHP's P/E ratio is -2.80. In terms of profitability, DMTRF's ROE is -0.24%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, DMTRF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs NGMDF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, NGMDF has a market cap of 9.8M. Regarding current trading prices, DMTRF is priced at $0.69, while NGMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas NGMDF's P/E ratio is -0.01. In terms of profitability, DMTRF's ROE is -0.24%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, DMTRF is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs IRME Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, IRME has a market cap of 7.9M. Regarding current trading prices, DMTRF is priced at $0.69, while IRME trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas IRME's P/E ratio is -3.67. In terms of profitability, DMTRF's ROE is -0.24%, compared to IRME's ROE of +11.77%. Regarding short-term risk, DMTRF is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs TBRIF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, TBRIF has a market cap of 6.4M. Regarding current trading prices, DMTRF is priced at $0.69, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas TBRIF's P/E ratio is -1.40. In terms of profitability, DMTRF's ROE is -0.24%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, DMTRF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs MKEAF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, MKEAF has a market cap of 6.1M. Regarding current trading prices, DMTRF is priced at $0.69, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, DMTRF's ROE is -0.24%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, DMTRF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs DTXMF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, DTXMF has a market cap of 5.7M. Regarding current trading prices, DMTRF is priced at $0.69, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, DMTRF's ROE is -0.24%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, DMTRF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs QLIS Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, DMTRF is priced at $0.69, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas QLIS's P/E ratio is 2.22. In terms of profitability, DMTRF's ROE is -0.24%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, DMTRF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs RHNMF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, DMTRF is priced at $0.69, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, DMTRF's ROE is -0.24%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, DMTRF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs ALRTF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, ALRTF has a market cap of 5.4M. Regarding current trading prices, DMTRF is priced at $0.69, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas ALRTF's P/E ratio is -0.28. In terms of profitability, DMTRF's ROE is -0.24%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, DMTRF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs NUMD Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, NUMD has a market cap of 5M. Regarding current trading prices, DMTRF is priced at $0.69, while NUMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas NUMD's P/E ratio is 6.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, DMTRF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs MICR Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, MICR has a market cap of 4.7M. Regarding current trading prices, DMTRF is priced at $0.69, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas MICR's P/E ratio is -3.47. In terms of profitability, DMTRF's ROE is -0.24%, compared to MICR's ROE of -0.25%. Regarding short-term risk, DMTRF is more volatile compared to MICR. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs FZMD Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, FZMD has a market cap of 4.4M. Regarding current trading prices, DMTRF is priced at $0.69, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas FZMD's P/E ratio is 1.20. In terms of profitability, DMTRF's ROE is -0.24%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, DMTRF is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs LBLTF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, DMTRF is priced at $0.69, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, DMTRF's ROE is -0.24%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, DMTRF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs ADMT Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, ADMT has a market cap of 4.1M. Regarding current trading prices, DMTRF is priced at $0.69, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas ADMT's P/E ratio is -6.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, DMTRF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs PMEDF Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, PMEDF has a market cap of 4M. Regarding current trading prices, DMTRF is priced at $0.69, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas PMEDF's P/E ratio is -2.69. In terms of profitability, DMTRF's ROE is -0.24%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, DMTRF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs BIEL Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, BIEL has a market cap of 3.6M. Regarding current trading prices, DMTRF is priced at $0.69, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas BIEL's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is -0.24%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, DMTRF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs VANIW Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, DMTRF is priced at $0.69, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas VANIW's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is -0.24%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, DMTRF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs VYCO Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, VYCO has a market cap of 3.3M. Regarding current trading prices, DMTRF is priced at $0.69, while VYCO trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas VYCO's P/E ratio is -10.00. In terms of profitability, DMTRF's ROE is -0.24%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, DMTRF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs USAQ Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, USAQ has a market cap of 2.9M. Regarding current trading prices, DMTRF is priced at $0.69, while USAQ trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas USAQ's P/E ratio is -6.40. In terms of profitability, DMTRF's ROE is -0.24%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, DMTRF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.
DMTRF vs ESMC Comparison
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 76.1M. In comparison, ESMC has a market cap of 1.9M. Regarding current trading prices, DMTRF is priced at $0.69, while ESMC trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -9.86, whereas ESMC's P/E ratio is 5.01. In terms of profitability, DMTRF's ROE is -0.24%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, DMTRF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.